Biomarkers

Jan. 27, 2025

The Bio-Hermes-002 study aims to improve participation from people who are traditionally underrepresented in Alzheimer’s clinical research.

Biomarkers

Potential new way to detect dementia risk earlier supported by UCLA study

LABline

Dec. 18, 2024

Biomarkers

OncoHost announces new study on biomarkers for renal cell carcinoma

LABline

June 4, 2024

Biomarkers

Biomarker found to help identify cells that can repair damaged blood vessels

LABline

May 15, 2024

Biomarkers

Quest Diagnostics adds p-tau217 blood biomarker testing to suite of services designed to assess risk and help aid diagnosis of Alzheimer’s disease

LABline

April 23, 2024

Biomarkers

Neurofilament light chain: Unraveling the diagnostic and prognostic threads in neurological disorders

Dr. Thomas Kampfrath, PhD, DABCC, NRCC

March 25, 2024

Biomarkers

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

LABline

Feb. 6, 2024

UCLA-led research shows targeting the protein UCHL1 could lead to a new therapeutic approach for managing these cancers.

Biomarkers

Abnormal proteins found in the spinal fluid of people with ALS and frontotemporal dementia

LABline

Feb. 1, 2024

Proteins could serve as biomarkers that improve diagnosis and guide the development of novel therapies.

Biomarkers

New biomarkers for active lupus nephritis discovered

LABline

Jan. 30, 2024

Antibodies and DNA used to find the biological markers of disease.

Biomarkers

A blood test shows MS worsening 1 to 2 years before it happens

LABline

Dec. 8, 2023

Almost 1 million Americans suffer from MS.

Biomarkers

Urine biomarkers can outperform serum biomarkers in certain diseases

LABline

Nov. 28, 2023

The team acknowledges the challenges in realizing this potential, particularly the standardization of urinary biomarker assays and the expansion of the spectrum of diseases that...

Biomarkers

OncoHost to present proteomics-based predictive biomarker for immune-related adverse events in NSCLC Patients at SITC 2023

LABline

Nov. 1, 2023

Novel computational model predicts significant irAEs in NSCLC patients based on proteomic profiling of one pre-treatment blood test.

Biomarkers

Researchers discover biomarker for tracking depression recovery

LABline

Sept. 21, 2023

New deep brain stimulation device coupled with powerful AI may improve therapy for treatment-resistant depression.

Biomarkers

Blood biomarker shows “great promise” predicting progression to Alzheimer’s disease in at-risk population

LABline

Sept. 19, 2023

The review article, “The Potential of Blood Neurofilament Light as a Marker of Neurodegeneration in Alzheimer’s disease,” is published in the journal Brain.

Biomarkers

The ongoing troponin conundrum: Understanding an elevated troponin

Kalen Nissen, PhD, DABCC, FAACC

Aug. 24, 2023

As laboratory assays have evolved with improved performance, the clinical use of cardiac troponin (cTn) has also evolved beyond the context of myocardial infarction (MI). The ...

Biomarkers

Possible biomarker of MS-like autoimmune disease discovered

LABline

Aug. 16, 2023

MS research.

Biomarkers

Biomarkers

Study identifies biomarker for allergic reaction in kidneys

LABline

July 7, 2023

Biomarkers

Natriuretic peptides in heart failure

Zivjena Vucetic, MD, PhD

June 15, 2023

Biomarkers

Blood-based biomarkers challenge the standard approach for evaluation of traumatic brain injury (TBI) in acute care settings

Madeline Leafblad, MLS(ASCP)CM

June 15, 2023

Biomarkers

Study finds certain substances in urine, blood can predict kidney disease progression

LABline

April 5, 2023

Biomarkers

Researchers identify biomarker for diagnosing vascular dementia

LABline

Feb. 23, 2023

Biomarkers

Owlstone Medical publishes data on the use of exhaled volatile organic compounds as biomarkers for liver disease detection

LABline

Feb. 7, 2023

Biomarkers

New biomarker strategy devised to screen for, diagnose deadly heart complication from cancer treatment

LABline

Dec. 21, 2022

Beckman Coulter Diagnostics joins the Bio-Hermes-002 study as new partner

Potential new way to detect dementia risk earlier supported by UCLA study

OncoHost announces new study on biomarkers for renal cell carcinoma

Biomarker found to help identify cells that can repair damaged blood vessels

Quest Diagnostics adds p-tau217 blood biomarker testing to suite of services designed to assess risk and help aid diagnosis of Alzheimer’s disease

Neurofilament light chain: Unraveling the diagnostic and prognostic threads in neurological disorders

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

Abnormal proteins found in the spinal fluid of people with ALS and frontotemporal dementia

New biomarkers for active lupus nephritis discovered

A blood test shows MS worsening 1 to 2 years before it happens

Urine biomarkers can outperform serum biomarkers in certain diseases

OncoHost to present proteomics-based predictive biomarker for immune-related adverse events in NSCLC Patients at SITC 2023

Researchers discover biomarker for tracking depression recovery

Blood biomarker shows “great promise” predicting progression to Alzheimer’s disease in at-risk population

The ongoing troponin conundrum: Understanding an elevated troponin

Possible biomarker of MS-like autoimmune disease discovered

Biomarkers

Study identifies biomarker for allergic reaction in kidneys

Natriuretic peptides in heart failure

Blood-based biomarkers challenge the standard approach for evaluation of traumatic brain injury (TBI) in acute care settings

Study finds certain substances in urine, blood can predict kidney disease progression

Researchers identify biomarker for diagnosing vascular dementia

Owlstone Medical publishes data on the use of exhaled volatile organic compounds as biomarkers for liver disease detection

New biomarker strategy devised to screen for, diagnose deadly heart complication from cancer treatment